abagovomab 53
abciximab 45
abituzumab 33
abrilumab 32
actoxumab 32
adalimumab 22
aducanumab 19
afasevikumab 25
alacizumab_pegol 17
alemtuzumab 44
alirocumab 30
amatuximab 59
andecaliximab 37
anifrolumab 34
anrukinzumab 26
aprutumab 25
aprutumab_ixadotin 25
arcitumomab 32
ascrinvacumab 26
atezolizumab 17
atinumab 25
avelumab 22
basiliximab 57
bavituximab 54
begelomab 46
benralizumab 41
bevacizumab_beta 30
bezlotoxumab 32
bimagrumab 34
bleselumab 35
blinatumomab 57
blosozumab 39
bococizumab 34
brazikumab 23
brentuximab_vedotin 50
briakinumab 25
brodalumab 32
brolucizumab 33
brontictuzumab 39
burosumab 33
cabiralizumab 40
camrelizumab 17
canakinumab 31
cantuzumab_ravtansin 61
carlumab 31
carotuximab 40
cergutuzumab_amunaleukin2 41
cergutuzumab_amunaleukin 41
certolizumab_pegol 28
cetiximab 57
citatuzumab_bogatox 32
cixutumumab 50
clivatuzumab_tetraxetan 39
codrituzumab 44
conatumumab 28
concizumab 35
crenezumab 27
crizanlizumab 38
crotedumab 27
dacetuzumab 27
daclizumab 34
dalotuzumab 54
dapirolizumab_pegol 31
daratumumab 19
dectrekumab 15
demcizumab 44
denosumab 14
depatuxizumab 39
depatuxizumab_mafodotin 39
dezamizumab 36
dinutuximab 49
diridavumab 42
domagrozumab 20
drozitumab 32
duligotuzumab 21
durvalumab 21
dusigitumab 44
efalizumab 38
efungumab 40
eldelumab 25
elezanumab 39
elgemtumab 15
elotuzumab 24
emactuzumab 36
emapalumab 32
emibetuzumab 35
enavatuzumab 30
enfortumab_vedotin 19
enoblituzumab 25
enokizumab 37
enoticumab 29
ensituximab 52
eptinezumab 21
erenumab 35
etaracizumab 19
etrolizumab 25
evinacumab 26
evolocumab 39
farletuzumab 21
fasinumab 34
fezakinumab 42
fibatuzumab 36
ficlatuzumab 42
firivumab 45
flanvotumab 32
fletikumab 42
foralumab 23
foravirumab 19
fremanezumab 36
fresolimumab 31
fulranumab 27
futuximab 48
galcanezumab 31
ganitumab 47
gantenerumab 18
gemetuzumab 47
gemtuzumab2 41
gemtuzumab 49
gevokizumab 39
girentuximab 42
glembatumumab 38
glembatumumab_vedotin 38
guselkumab 35
ibalizumab 45
ibritumomab 57
icrucumab 23
idarucizumab 56
ifabotuzumab 36
imalumab 19
imgatuzumab 35
inclacumab 27
indatuximab_ravtansin 46
indusatumab 33
inebilizumab 39
intetumumab 27
iodine_girentuximab 35
ipilimumab 13
iratumumab 29
isatuximab 49
itolizumab 33
ixekizumab 46
labetuzumab_govitecan 35
lambrolizumab 39
lampalizumab 35
lanadelumab 21
landogrozumab 22
laprituximab 42
lebrikizumab 49
lendalizumab 38
lenzilumab 31
lifastuzumab_vedotin 28
ligelizumab 36
lilotomab 54
lirilumab 39
lodelcizumab 35
lokivetmab 31
lorvotuzumab_mertansin 32
lucatumumab 35
lumretuzumab 37
lupartumab 24
lutikizumab 23
margetuximab 51
milatuzumab 52
mirvetuximab 53
mirvetuximab_soravtansin 53
modotuximab 59
mogamulizumab 38
monalizumab 37
motavizumab 48
moxetumomab_pasudotox 36
namilumab 39
naratuximab 45
naratuximab_emtansin 45
narnatumab 26
navicixizumab2 42
navicixizumab 45
navivumab 50
necitumumab 29
nemolizumab 41
nesvacumab 21
nivolumab 23
obiltoxaximab 38
obinutuzumab 47
ocaratuzumab 37
ofatumumab 25
olaratumab 36
olokizumab 30
omalizumab 24
onartuzumab 27
ontuxizumab 43
opicinumab 19
orticumab 18
otelixizumab 45
oxelumab 16
ozanezumab 48
pamrevlumab 15
panobacumab 34
parsatuzumab 34
pasotuxizumab 23
pateclizumab 25
patritumab 41
pembrolizumab 39
perakizumab 27
pidilizumab 32
pinatuzumab_vedotin 22
plozalizumab 38
pogalizumab 36
polatuzumab_vedotin 27
ponezumab 49
prezalumab 18
pritoxaximab 59
quilizumab 24
racotumomab 47
radretumab 20
ralpancizumab 37
ramucirumab 18
ranevetmab 39
ranibizumab 30
refanezumab 37
remtolumab 22
rilotumumab 39
rinucumab 40
risankizumab 48
rituximab 44
rivabazumab 28
robatumumab 22
roledumab 38
romosozumab 37
rontalizumab 29
rosmantuzumab 40
rozanolixizumab 31
sacituzumab 41
sacituzumab_govitecan 41
samalizumab 38
sapelizumab 38
sarilumab 21
secukinumab 27
seribantumab 20
setoxaximab 58
sifalimumab 31
siltuximab 39
simtuzumab 41
sirukumab 20
solanezumab 29
solitomab 45
stamulumab 37
suptavumab 33
suvizumab 35
tabalumab 33
tadocizumab 29
tamtuvetmab 44
tanezumab 39
tarextumab 16
tavolixizumab 32
telisotuzumab 45
teplizumab 32
tesidolumab 46
tezepelumab 38
tigatuzumab 20
tildrakizumab 33
timolumab 22
tisotumab 18
tosatoxumab 55
tositumomab 56
tralokinumab 49
trastuzumab 26
tregalizumab 36
trevogrumab 20
ublituximab 50
urelumab 40
ustekinumab 36
utomilumab 45
vadastuximab 41
vadastuximab_talirin 41
vandortuzumab_vedotin 27
vantictumab 33
vanucizumab2 30
vanucizumab 56
varlilumab 21
vatelizumab 39
vedolizumab 45
veltuzumab 37
vesencumab 16
vorsetuzumab 42
vorsetuzumab_mafodotin 42
vunakizumab 52
xentuzumab 25
zatuximab 59
